RFP Open: Prime Gene Editing Strategies or Cell Therapy

We are pleased to announce a Request for Proposal (RFP) for high-impact research on prime gene editing strategies or cell therapy to address the increase in SMAD4 activity.

Proposals will be accepted for Team Science Awards, which are defined as collaborative research amongst investigators with experience in gene-editing strategies or cell therapy in or outside the Myhre syndrome field. 

We expect to provide up to $450,000 over three years to undertake projects that have the clear potential to lead to gene therapies or cell therapy for Myhre syndrome patients.

Please click here for the full RFP.

Key Dates*:
July 1, 2024 - Letter of Intent due.
July 8, 2024 - Selected LOIs are invited to submit full-length proposals.
Sept 2, 2024 - Full-length proposal due.
Oct 14, 2024 - Peer and organizational reviews/modifications of submissions due.
Oct 28, 2024 - Award letters/negotiate research agreements
Nov 11, 2024 - Projects commence.

*Subject to change if an extended review period is needed.

Please submit Letters of Intent or any questions regarding the RFP to kwears@myhresyndrome.org

Grant Overhead Policy
Myhre Syndrome Foundation will not support indirect costs, overhead costs, or other similar institutional levies in excess of 5% of the total award amount. Fringe benefits for personnel salaries are allowable.